FDA Regulatory Compliance Advisors, Inc.™
Lack of sterility assurance and microbial contamination have been, and continue to be, major reasons for recalls of drug products.
Because microbial contamination in drug products represents such a high risk for patients, FDA takes swift enforcement actions against pharmaceutical companies that fail to implement the necessary controls to prevent it.
FDA-RCA’s wealth of experience evaluating sterile manufacturing processes and controls is at your company’s disposition to prevent the serious regulatory and financial hurdles that result from the distribution of possibly contaminated products to the market.
Ensuring the sterility of pharmaceutical products requires the implementation of GMP-compliant procedures and practices, and suitable facility design and equipment.
The variety of processes used to manufacture sterile products require validation and control, since each process could introduce an error that ultimately could lead to the distribution of a contaminated product.
"Avoid Expensive Product Recalls"
© 2018, FDA Regulatory Compliance Advisors, Inc., "All Rights Reserved".
SIX KEY SUCCESS AREAS:
FDA REGULATORY COMPLIANCE ADVISORS, INC.
P.O. BOX 31195
SAN JUAN, P.R. 00929-2195
PHONE: (787) 755-7841
MOBILE: (787) 390-6020